secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vicarious Surgical Inc. (RBOT)
CIK:        0001812173
Form:       8-K
Filed at:   2025-09-23T23:59:59+00:00
Accession:  0001213900-25-090683
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vicarious Surgical completes controlled builds; on track for production-equivalent system by mid-2026
--------------------------------------------------------------------------------

- Controlled builds completed in April and August 2025 under full QMS, demonstrating reproducibility and scalability.
- System functionality increased from 49% (June) to 63% (Sept 2025); on path to 100% by mid-2026.
- Launch indication is ventral hernia repair; 66% of US ventral hernias are still performed open (Fry et al. 2024).
- Targeting clinical readiness by year-end 2026 and human clinical trials in 2027 to support De Novo submission.
- IP portfolio includes 160 patents (50 granted/allowed, 110 pending) covering core innovations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1812173/000121390025090683/0001213900-25-090683-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1812173/000121390025090683/ea0258510-8k_vicarious.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-090683

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer